FEBS Open Bio是一個經同行評審的每月開放獲取科學期刊，涵蓋分子和細胞生命科學的研究。它成立于2011年，由John Wiley & Sons代表歐洲生化學會聯合會(FEBS)出版。《華爾街日報》稱，論文不能因為缺乏重要性而被排除在外。最初提交給其他FEBS期刊(FEBS Letters, FEBS Journal, Molecular Oncology)的文章可以連同其原始審稿人報告一起轉到該期刊，而不需要重新提交或重新排版原稿。

FEBS Open Bio is a monthly peer-reviewed open access scientific journal covering research in molecular and cellular life sciences. It was established in 2011 and is published by John Wiley & Sons on behalf of the Federation of European Biochemical Societies (FEBS). According to the journal, papers are not to be excluded on the basis of lack of perceived importance.Articles originally submitted to other FEBS journals (FEBS Letters, The FEBS Journal, and Molecular Oncology) can be transferred to this journal with their original reviewer reports, without the need to resubmit or reformat the manuscript.